Imaging Biometrics Ltd. (LON:IBAI)

London · Delayed Price · Currency is GBP · Price in GBX

0.8000

+0.0850 (11.89%)

Sep 4, 2026, 3:23 PM GMT

Market Cap	1.97M +27.0%
Revenue (ttm)	810.42K +15.8%
Net Income	-237.44K
EPS	-0.00
Shares Out	246.71M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	367,392
Open	0.7200
Previous Close	0.7150
Day's Range	0.7200 - 0.8750
52-Week Range	0.4000 - 1.4000
Beta	0.94
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About Imaging Biometrics

Imaging Biometrics Ltd. provides clinical treatments to patients in the field of medical imaging diagnostics in the United Kingdom, China, the European Union, South America, Australia, and the United States. It operates through Holding Company, Medical Software, Oral Gallium Maltolate (GaM), and Organ-on-a-Chip segments. The company develops ready-to-use software applications comprising IB Neuro, an MRI perfusion platform that generates quantitative relative cerebral blood volume maps; IB Delta T1 maps, an image processing tool kit containing f... [Read more]

Industry Medical - Healthcare Information Services

Sector Healthcare

Founded 1965

Employees 7

Stock Exchange London Stock Exchange

Ticker Symbol IBAI

Full Company Profile

Financial Performance

In 2025, Imaging Biometrics's revenue was 788,148, an increase of 5.07% compared to the previous year's 750,105. Losses were -400,940, 22.6% more than in 2024.

Financial Statements